α
AlphaScala
StocksSignalsNEWAlpha ScoreBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsAlpha ScoreHedge Funds 13FInsider BuysAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

For AI AgentsAlphaScala is agent-ready —skill.md·llms.txt
© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala — Built with data, not hype.
All Stocks/Healthcare/CI

Cigna Group

CINYSE
HealthcareHealthcare Plans Website
Alpha Score
51
Weak
Signal SnapshotMarket signals →
Alpha Score
51 · Weak
Alpha Score of 51 reflects moderate overall profile with moderate momentum, weak value, moderate qualit...
Updated May 3
Insider Activity
-$1.2M net
0 buys and 2 sells in the 90-day rollup.
Form 4 · Mar 2
13F Holder
Citadel
$243.80M reported position; latest action: new.
Ken Griffin
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about CIAI research agent
Alpha Score BreakdownHow it works →

Alpha Score of 51 reflects moderate overall profile with moderate momentum, weak value, moderate quality, moderate sentiment.

Momentum
54
Weak
Value
41
Weak
Quality
58
Moderate
Sentiment
50
Weak
Key StatisticsUpdated Apr 15
P/E Ratio
31.88
Forward P/E
—
PEG Ratio
—
EPS (TTM)
8.55
Dividend Yield
2.29%
Beta
0.27
Revenue (TTM)
—
Net Margin
2.17%
ROE
14.53%
Debt / Equity
0.75
52W High
$340.04
52W Low
$244.41
Daily CommentaryAI-written, data-grounded

Cigna Group Performance Analysis Amidst Strong EPS Growth and Valuation Metrics

Apr 15, 2026

Cigna Group (CI) currently trades at $340.04, positioning the stock at the upper bound of its 52-week range. The primary driver for recent market attention remains the significant 80.9% year-over-year EPS growth, which contrasts sharply with the company’s 11.2% revenue growth. Despite the robust earnings expansion, the stock maintains a P/E ratio of 31.88, reflecting investor expectations for future profitability. The firm’s net margin stands at 2.2%, highlighting the thin-margin nature of the healthcare sector even as earnings scale upward. From a technical perspective, the Alpha Score of 47.4 suggests a neutral market stance. The quality sub-score of 58.4 is the strongest component, indicating relative stability in operational execution compared to the momentum score of 42.2 and the value score of 40.5. Sentiment remains balanced at 50, suggesting that current price levels are well-supported by existing data but lack a clear directional catalyst. Investors should monitor whether the company can sustain its current EPS growth trajectory while managing margin pressures throughout the remainder of the fiscal quarter.

Insider ActivitySEC Form 4 filings
Buys (90d)
0
Sells (90d)
2
Net $ (90d)
$-1.2M
Unique insiders
2
DateInsiderRoleTypeSharesValue
Mar 2, 26Neville EverettSee RemarksSELL1.7K$497K
Mar 2, 26Jones Nicole SSee RemarksSELL2.3K$667K
Nov 3, 25Cordani DavidChairman & CEOBUY4.1K$1000K
See cluster-buy signals across all tickers →
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
886K$243.80MNEW
D.E. Shaw
David Shaw
309K$85.09MNEW
Point72
Steve Cohen
154K$42.28MNEW
Renaissance Technologies
Jim Simons (founder)
47K$12.86MNEW
Marshall Wace908$249.9KNEW
Explore all tracked funds →
About Cigna Group

The Cigna Group is a global health services organization dedicated to providing a broad range of insurance products and related services. Its core offerings encompass medical, dental, behavioral health, pharmacy benefit management, vision care, and supplemental benefits. Through the Evernorth Health Services segment, it partners with health plans, employers, governmental organizations, and providers to address challenges in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery management. The Cigna Healthcare segment delivers comprehensive medical and coordinated solutions via U.S. Healthcare and International Health operations. Other Operations include ongoing and exited businesses, while Corporate handles interest expenses, litigation, pension plans, and overhead. The Cigna Group connects clients with providers, pharmacies, and wellness partners across the United States and select international markets in Asia, Europe, the Middle East, and Latin America, emphasizing integrated solutions for clinical needs and cost efficiency. Founded in 1792 and headquartered in Bloomfield, Connecticut, it serves individuals, employers, and organizations with data-driven care management and digital health tools.

CEO
Mr. David Michael Cordani
Employees
65,669
Quick Facts
ExchangeNYSE
SectorHealthcare
IndustryHealthcare Plans
Market Cap—
Avg Volume1.11M
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when CI reports next.

Get earnings alerts →